Richard I. Lindley
University of Sydney
335 Papers
1.4K Citations
Richard I. Lindley is an academic researcher from University of Sydney. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 54, co-authored 313 publications. Previous affiliations of Richard I. Lindley include Florey Institute of Neuroscience and Mental Health & University of Newcastle.
Chat about Author
Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Joanna M. Wardlaw,Eric E. Smith,Geert J. Biessels,Charlotte Cordonnier,Franz Fazekas,Richard Frayne,Richard I. Lindley,John T. O'Brien,Frederik Barkhof,Oscar R. Benavente,Sandra E. Black,Carol Brayne,Monique M.B. Breteler,Hugues Chabriat,Charles DeCarli,Frank-Erik de Leeuw,Fergus N. Doubal,Marco Duering,Nick C. Fox,Steven M. Greenberg,Vladimir Hachinski,Ingo Kilimann,Vincent Mok,Robert J. van Oostenbrugge,Leonardo Pantoni,Oliver Speck,Blossom C. M. Stephan,Stefan J. Teipel,Anand Viswanathan,David J. Werring,Christopher Chen,Colin Smith,Mark A. van Buchem,Bo Norrving,Philip B. Gorelick,Martin Dichgans +35 more
TL;DR: This Position Paper summarises the main outcomes of this international effort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE).
4.8K
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson,Kennedy R. Lees,Patrick D. Lyden,Lisa Blackwell,Gregory W. Albers,Erich Bluhmki,Thomas G. Brott,Geoff Cohen,Stephen M. Davis,Geoffrey A. Donnan,James C. Grotta,George Howard,Markku Kaste,Masatoshi Koga,Ruediger von Kummer,Maarten G Lansberg,Richard I. Lindley,Gordon D Murray,Jean-Marc Olivot,Mark W Parsons,Barbara C. Tilley,Danilo Toni,Kazunori Toyoda,Nils Wahlgren,Joanna M. Wardlaw,William Whiteley,Gregory J. del Zoppo,Colin Baigent,Peter Sandercock,Werner Hacke +29 more
TL;DR: In this paper, a pre-specifi ed meta-analysis of individual patient data from 6756 patients in nine randomised trials comparing alteplase with placebo or open control was conducted.
2.3K
The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
Peter Sandercock,Rory Collins,Carl Counsell,Barbara Farrell,Richard Peto,Jim Slattery,Charles Warlow,S Anderson,A Bowie,J Boyle,A Brownlie,D Charlton,Gina Cranswick,L Day,Martin Dennis,Paul Dorman,H Fraser,M Kaye,Richard I. Lindley,M Liu,C MacDonald,I McCrindle,G Middleton,D. Perry,V Scoltock,Brenda Smith,Hugh R. Taylor,Fiona Waddell,Joanna Wardlaw,J Crowther,J Heineman,S Knight,Andrew Radley,R Ripley,S Richards,S Wilberforce,Zhengming Chen,J vanGijn,Michael R. Harrison,Lars Wilhelmsen +39 more
TL;DR: Aspirinallocated patients had significantly fewer recurrent ischaemic strokes within 14 days with no significant excess of haemorrhagic strokes, so the reduction in death or non-fatal recurrent stroke with aspirin was significant.
1.8K
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage
Craig S. Anderson,Emma Heeley,Yining Huang,Jiguang Wang,Christian Stapf,Candice Delcourt,Richard I. Lindley,Thompson G. Robinson,Pablo M. Lavados,Pablo M. Lavados,Bruce Neal,Jun Hata,Jun Hata,Hisatomi Arima,Mark W Parsons,Yuechun Li,J. Wang,Stephane Heritier,Qiang Li,Mark Woodward,Mark Woodward,R. John Simes,Stephen M. Davis,John Chalmers +23 more
TL;DR: In patients with intracerebral hemorrhage, intensive lowering of blood pressure did not result in a significant reduction in the rate of the primary outcome of death or severe disability, and an ordinal analysis of modified Rankin scores indicated improved functional outcomes with intensive loweringof blood pressure.
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Peter Sandercock,Joanna M. Wardlaw,Richard I. Lindley,Martin Dennis,Geoff Cohen,Gordon D Murray,Karen Innes,Graham Venables,Anna Członkowska,Adam Kobayashi,Stefano Ricci,Veronica Murray,Eivind Berge,Karsten Bruins Slot,Graeme J. Hankey,Manuel Correia,André Peeters,Karl Matz,P. A. Lyrer,Gord Gubitz,Stephen J. Phillips,Antonio Arauz +21 more
TL;DR: For the types of patient recruited in IST-3, despite the early hazards, thrombolysis within 6 h improved functional outcome and benefit did not seem to be diminished in elderly patients.
1.2K